Historial de precios de acciones de sun pharma bse
Sunpharma financial results, Sunpharma shareholding, Sunpharma annual Group, A. Index, S&P BSE SENSEX. Industry, Pharmaceuticals For Buy-Back Of Equity Shares And Intimation Of Closure Of The Trading Window, 12/03/2020 Tell a Friend Print Home » Investors » Shareholder's Information » Stock Information. Financials · Annual Reports & Find Sunpharma's BSE information, to Sun Pharma Share Price, Sun Pharma Stock Price, Sun Pharmaceutical Industries Ltd. Stock/Share prices, Sun Pharmaceutical Industries Ltd. Live BSE/ NSE, F&O Quote Experts & Broker view on Sun Pharmaceutical Industries Ltd. buy sell tips. Vedanta on verge of a breakdown, sell March futures for a target of Rs 126. 6 days ago Shares of the drugmaker were up nearly a percent at Rs 369 apiece on the BSE, compared with a decline of 2.64 percent in the S&P BSE Sensex 6 days ago Sun Pharma approved the buy back of 4 crore shares of the company at Rs 425 per share. back of 4 crore shares of the company at Rs 425, a premium of 15.48 per cent from the last close. Company Summary. NSE. BSE
Sunpharma financial results, Sunpharma shareholding, Sunpharma annual Group, A. Index, S&P BSE SENSEX. Industry, Pharmaceuticals For Buy-Back Of Equity Shares And Intimation Of Closure Of The Trading Window, 12/03/2020
Sunpharma financial results, Sunpharma shareholding, Sunpharma annual Group, A. Index, S&P BSE SENSEX. Industry, Pharmaceuticals For Buy-Back Of Equity Shares And Intimation Of Closure Of The Trading Window, 12/03/2020 Tell a Friend Print Home » Investors » Shareholder's Information » Stock Information. Financials · Annual Reports & Find Sunpharma's BSE information, to Sun Pharma Share Price, Sun Pharma Stock Price, Sun Pharmaceutical Industries Ltd. Stock/Share prices, Sun Pharmaceutical Industries Ltd. Live BSE/ NSE, F&O Quote Experts & Broker view on Sun Pharmaceutical Industries Ltd. buy sell tips. Vedanta on verge of a breakdown, sell March futures for a target of Rs 126. 6 days ago Shares of the drugmaker were up nearly a percent at Rs 369 apiece on the BSE, compared with a decline of 2.64 percent in the S&P BSE Sensex 6 days ago Sun Pharma approved the buy back of 4 crore shares of the company at Rs 425 per share. back of 4 crore shares of the company at Rs 425, a premium of 15.48 per cent from the last close. Company Summary. NSE. BSE
6 days ago Sun Pharma approved the buy back of 4 crore shares of the company at Rs 425 per share. back of 4 crore shares of the company at Rs 425, a premium of 15.48 per cent from the last close. Company Summary. NSE. BSE
6 days ago Sun Pharma approved the buy back of 4 crore shares of the company at Rs 425 per share. back of 4 crore shares of the company at Rs 425, a premium of 15.48 per cent from the last close. Company Summary. NSE. BSE
Sun Pharma Share Price, Sun Pharma Stock Price, Sun Pharmaceutical Industries Ltd. Stock/Share prices, Sun Pharmaceutical Industries Ltd. Live BSE/ NSE, F&O Quote Experts & Broker view on Sun Pharmaceutical Industries Ltd. buy sell tips. Vedanta on verge of a breakdown, sell March futures for a target of Rs 126.
Sunpharma financial results, Sunpharma shareholding, Sunpharma annual Group, A. Index, S&P BSE SENSEX. Industry, Pharmaceuticals For Buy-Back Of Equity Shares And Intimation Of Closure Of The Trading Window, 12/03/2020 Tell a Friend Print Home » Investors » Shareholder's Information » Stock Information. Financials · Annual Reports & Find Sunpharma's BSE information, to Sun Pharma Share Price, Sun Pharma Stock Price, Sun Pharmaceutical Industries Ltd. Stock/Share prices, Sun Pharmaceutical Industries Ltd. Live BSE/ NSE, F&O Quote Experts & Broker view on Sun Pharmaceutical Industries Ltd. buy sell tips. Vedanta on verge of a breakdown, sell March futures for a target of Rs 126. 6 days ago Shares of the drugmaker were up nearly a percent at Rs 369 apiece on the BSE, compared with a decline of 2.64 percent in the S&P BSE Sensex
Sun Pharma Share Price, Sun Pharma Stock Price, Sun Pharmaceutical Industries Ltd. Stock/Share prices, Sun Pharmaceutical Industries Ltd. Live BSE/ NSE, F&O Quote Experts & Broker view on Sun Pharmaceutical Industries Ltd. buy sell tips. Vedanta on verge of a breakdown, sell March futures for a target of Rs 126.
Sunpharma financial results, Sunpharma shareholding, Sunpharma annual Group, A. Index, S&P BSE SENSEX. Industry, Pharmaceuticals For Buy-Back Of Equity Shares And Intimation Of Closure Of The Trading Window, 12/03/2020 Tell a Friend Print Home » Investors » Shareholder's Information » Stock Information. Financials · Annual Reports & Find Sunpharma's BSE information, to Sun Pharma Share Price, Sun Pharma Stock Price, Sun Pharmaceutical Industries Ltd. Stock/Share prices, Sun Pharmaceutical Industries Ltd. Live BSE/ NSE, F&O Quote Experts & Broker view on Sun Pharmaceutical Industries Ltd. buy sell tips. Vedanta on verge of a breakdown, sell March futures for a target of Rs 126. 6 days ago Shares of the drugmaker were up nearly a percent at Rs 369 apiece on the BSE, compared with a decline of 2.64 percent in the S&P BSE Sensex 6 days ago Sun Pharma approved the buy back of 4 crore shares of the company at Rs 425 per share. back of 4 crore shares of the company at Rs 425, a premium of 15.48 per cent from the last close. Company Summary. NSE. BSE
Sunpharma financial results, Sunpharma shareholding, Sunpharma annual Group, A. Index, S&P BSE SENSEX. Industry, Pharmaceuticals For Buy-Back Of Equity Shares And Intimation Of Closure Of The Trading Window, 12/03/2020 Tell a Friend Print Home » Investors » Shareholder's Information » Stock Information. Financials · Annual Reports & Find Sunpharma's BSE information, to Sun Pharma Share Price, Sun Pharma Stock Price, Sun Pharmaceutical Industries Ltd. Stock/Share prices, Sun Pharmaceutical Industries Ltd. Live BSE/ NSE, F&O Quote Experts & Broker view on Sun Pharmaceutical Industries Ltd. buy sell tips. Vedanta on verge of a breakdown, sell March futures for a target of Rs 126. 6 days ago Shares of the drugmaker were up nearly a percent at Rs 369 apiece on the BSE, compared with a decline of 2.64 percent in the S&P BSE Sensex 6 days ago Sun Pharma approved the buy back of 4 crore shares of the company at Rs 425 per share. back of 4 crore shares of the company at Rs 425, a premium of 15.48 per cent from the last close. Company Summary. NSE. BSE